プロテオミクスの世界市場予測（～2021）：器具別、試薬＆サービス別（ 分光学、クロマトグラフィ、電気泳動、イムノアッセイ、HPLC、X線結晶解析、質量分析、 表面プラズモン共鳴）、用途別...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Proteomics Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Proteomics Market Size Estimation
2.3 Proteomics Market Breakdown and Data Triangulation
2.4 Proteomics Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 36)
4.1 Global Proteomics Market Overview
4.2 Asia-Pacific: Proteomics Market Share, By Application (2015)
4.3 Geographic Snapshot of the Proteomics Market
4.4 Geographic Mix: Proteomics Market
4.5 Proteomics Market: Developed vs Developing Countries

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Key Proteomics Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Demand for Personalized Medicine
5.2.1.2 Proteomics Bridges the Gap Between Genome Sequence and Cellular Behavior
5.2.1.3 Increasing Pharmaceutical and Biotech R&D Expenditure
5.2.1.4 Technological Advancements
5.2.1.5 Availability of Government and Private Funding
5.2.2 Key Market Restraints
5.2.2.1 Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research
5.2.2.2 Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
5.2.2.3 Expensive Tools and Instruments and Their Maintenance
5.2.3 Key Market Opportunities
5.2.3.1 Growing Applications of Nanotechnology
5.2.3.2 Biomarker Identification
5.2.3.3 Untapped Emerging Markets
5.2.4 Key Market Challenges
5.2.4.1 Managing Large Volumes of Data Generated in Proteomics Research
5.2.4.2 Dearth of Skilled Researchers and Mandatory Training Cost

6 Industry Insights (Page No. – 49)
6.1 Introduction
6.2 Industry Trends
6.2.1 Shift From Genomics to Proteomics
6.2.2 Growing Number of Collaborations in Proteomics Market
6.3 Product Portfolio Analysis
6.4 Regulatory Analysis
6.4.1 North America

7 Global Proteomics Market, By Instrumentation Technology (Page No. – 54)
7.1 Introduction
7.2 Protein Microarrays
7.2.1 Biochips
7.2.1.1 Protein Chips
7.2.1.2 Lab-On-Chips (Microfluidics)
7.2.2 Microarray Instruments
7.2.2.1 Integrated Systems
7.2.2.2 Arrayers
7.2.2.3 Microarray Scanners
7.3 Spectroscopy
7.3.1 Mass Spectrometry
7.3.2 NMR Spectroscopy
7.3.3 CD Spectroscopy
7.4 X-Ray Crystallography
7.5 Chromatography
7.5.1 HPLC
7.5.2 Ion Chromatography
7.5.3 Affinity Chromatography
7.5.4 Supercritical Fluid Chromatography
7.6 Electrophoresis
7.6.1 Gel Electrophoresis
7.6.2 Capillary Electrophoresis
7.7 Surface Plasmon Resonance (SPR)
7.8 Protein Fractionation

8 Global Proteomics Market, By Reagent (Page No. – 86)
8.1 Introduction
8.2 Protein Microarray Reagents
8.3 Spectroscopy Reagents
8.4 X-Ray Crystallography Reagents
8.5 Chromatography Reagents
8.6 Electrophoresis Reagents
8.7 Immunoassay Reagents
8.8 Protein Fractionation Reagents

9 Global Proteomics Market, By Services and Software (Page No. – 96)
9.1 Introduction
9.2 Analytical Laboratory Services
9.2.1 Protein Identification
9.2.2 Protein Separation
9.2.3 Protein Sequencing
9.3 Data Analysis & Maintenance
9.3.1 Bioinformatics Databases
9.3.2 Bioinformatics Tools
9.4 Quantitation Services

10 Global Proteomics Market, By Application (Page No. – 109)
10.1 Introduction
10.2 Drug Discovery
10.3 Clinical Diagnostics
10.4 Other Proteomics Applications

11 Global Proteomics Market, By Region (Page No. – 116)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 Italy
11.3.4 U.K.
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia-Pacific
11.4.1 China
11.4.2 India
11.4.3 Japan
11.4.4 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa

12 Competitive Landscape (Page No. – 173)
12.1 Overview
12.2 Strategic Benchmarking
12.2.1 Increasing Focus on Product Launches and Enhancements
12.3 Market Ranking Analysis
12.3.1 Proteomic Instrumentation Technology
12.3.2 Proteomic Reagents
12.3.3 Proteomics Services and Software
12.4 Competitive Situations and Trends
12.4.1 Product Launches and Enhancements
12.4.2 Partnerships, Agreements, Collaborations, and Alliances
12.4.3 Acquisitions
12.4.4 Expansions

13 Company Profiles (Page No. – 185)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 Thermo Fisher Scientific, Inc.
13.3 Agilent Technologies, Inc.
13.4 Bio-Rad Laboratories, Inc.
13.5 Merck KGaA
13.6 Danaher Corporation
13.7 Luminex Corporation
13.8 Perkinelmer, Inc.
13.9 Waters Corporation
13.10 GE Healthcare
13.11 Bruker Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 239)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details